These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27080242)

  • 1. Accounting for data variability, a key factor in in vivo/in vitro relationships: application to the skin sensitization potency (in vivo LLNA versus in vitro DPRA) example.
    Dimitrov S; Detroyer A; Piroird C; Gomes C; Eilstein J; Pauloin T; Kuseva C; Ivanova H; Popova I; Karakolev Y; Ringeissen S; Mekenyan O
    J Appl Toxicol; 2016 Dec; 36(12):1568-1578. PubMed ID: 27080242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network-based risk assessment model of skin sensitization.
    Hirota M; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Takenouchi O; Ashikaga T; Miyazawa M
    J Appl Toxicol; 2015 Nov; 35(11):1333-47. PubMed ID: 25824844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals.
    Takenouchi O; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Hirota M; Ashikaga T; Miyazawa M
    J Appl Toxicol; 2015 Nov; 35(11):1318-32. PubMed ID: 25820183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening (HTS)-based spectrophotometric direct peptide reactivity assay (Spectro-DPRA) to predict human skin sensitization potential.
    Cho SA; An S; Park JH
    Toxicol Lett; 2019 Oct; 314():27-36. PubMed ID: 31295538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of skin sensitization potency using machine learning approaches.
    Zang Q; Paris M; Lehmann DM; Bell S; Kleinstreuer N; Allen D; Matheson J; Jacobs A; Casey W; Strickland J
    J Appl Toxicol; 2017 Jul; 37(7):792-805. PubMed ID: 28074598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of skin sensitization potency sub-categories using peptide reactivity data.
    Wareing B; Urbisch D; Kolle SN; Honarvar N; Sauer UG; Mehling A; Landsiedel R
    Toxicol In Vitro; 2017 Dec; 45(Pt 1):134-145. PubMed ID: 28882705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing.
    Natsch A; Emter R; Ellis G
    Toxicol Sci; 2009 Jan; 107(1):106-21. PubMed ID: 18832184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy.
    Jaworska JS; Natsch A; Ryan C; Strickland J; Ashikaga T; Miyazawa M
    Arch Toxicol; 2015 Dec; 89(12):2355-83. PubMed ID: 26612363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of amino acid derivative reactivity assay (4 mM) for the prediction of skin sensitization by combining multiple alternative methods to evaluate key events.
    Imamura M; Yamamoto Y; Fujita M; Wanibuchi S; Nakashima N; Kojima H; Ono A; Kasahara T
    J Appl Toxicol; 2022 Jul; 42(7):1159-1167. PubMed ID: 34993977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating skin sensitization potency from a single dose LLNA.
    Roberts DW
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):437-43. PubMed ID: 25625585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of an Integrated Testing Strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates.
    Ohtake T; Maeda Y; Hayashi T; Yamanaka H; Nakai M; Takeyoshi M
    Toxicology; 2018 Jan; 393():9-14. PubMed ID: 29100879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database.
    Hoffmann S; Kleinstreuer N; Alépée N; Allen D; Api AM; Ashikaga T; Clouet E; Cluzel M; Desprez B; Gellatly N; Goebel C; Kern PS; Klaric M; Kühnl J; Lalko JF; Martinozzi-Teissier S; Mewes K; Miyazawa M; Parakhia R; van Vliet E; Zang Q; Petersohn D
    Crit Rev Toxicol; 2018 May; 48(5):344-358. PubMed ID: 29474128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probabilistic hazard assessment for skin sensitization potency by dose-response modeling using feature elimination instead of quantitative structure-activity relationships.
    Luechtefeld T; Maertens A; McKim JM; Hartung T; Kleensang A; Sá-Rocha V
    J Appl Toxicol; 2015 Nov; 35(11):1361-1371. PubMed ID: 26046447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro human skin test for assessing sensitization potential.
    Ahmed SS; Wang XN; Fielding M; Kerry A; Dickinson I; Munuswamy R; Kimber I; Dickinson AM
    J Appl Toxicol; 2016 May; 36(5):669-84. PubMed ID: 26251951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated decision strategies for skin sensitization hazard.
    Strickland J; Zang Q; Kleinstreuer N; Paris M; Lehmann DM; Choksi N; Matheson J; Jacobs A; Lowit A; Allen D; Casey W
    J Appl Toxicol; 2016 Sep; 36(9):1150-62. PubMed ID: 26851134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can currently available non-animal methods detect pre and pro-haptens relevant for skin sensitization?
    Patlewicz G; Casati S; Basketter DA; Asturiol D; Roberts DW; Lepoittevin JP; Worth AP; Aschberger K
    Regul Toxicol Pharmacol; 2016 Dec; 82():147-155. PubMed ID: 27569201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LLNA variability: An essential ingredient for a comprehensive assessment of non-animal skin sensitization test methods and strategies.
    Hoffmann S
    ALTEX; 2015; 32(4):379-83. PubMed ID: 26168096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstructed human epidermis-based testing strategy of skin sensitization potential and potency classification using epidermal sensitization assay and in silico data.
    Mizumachi H; Suzuki S; Sakuma M; Natsui M; Imai N; Miyazawa M
    J Appl Toxicol; 2024 Mar; 44(3):415-427. PubMed ID: 37846211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.